Most Recent Additions*
Approvals and Timing of New Formulations of Novel Drugs Approved by the US Food and Drug Administration Between 1995 and 2010 and Followed Through 2021
Ravi Gupta, Michael J. Crescenz, Christopher J. Morten, Angela j. Zhu, Reshma Ramachandran, Nilay D. Shah, and Joseph S. Ross
The WTO Dispute Settlement System: How, Why and Where?
Petros C. Mavroidis
Agents of Inequality: Common Ownership and the Decline of the American Worker
Zohar Goshen and Doron Levit
Floors and Ceilings in International Copyright Treaties: Berne/TRIPS/WCT Minima and Maxima
Jane C. Ginsburg
Peaceful Resolution of Disputes
Lori Fisler Damrosch
Illiberalism and Administrative Government
Jeremy K. Kessler
International Investment Governance and Achieving a Just Zero-Carbon Future
Ella Merrill, Martin Dietrich Brauch, and Lisa E. Sachs
Investment Incentives: A Survey of Policies and Approaches for Sustainable Investment
Lise Johnson and Perrine Toledano
A Time for Triage
Michael B. Gerrard
Crime and the Corporation: Making the Punishment Fit the Corporation
John C. Coffee Jr.
Why Lingle is Half Right
Thomas W. Merrill
The United States Supreme Court: An Introduction
Bert I. Huang
Experimentalist Equal Protection
Brandon L. Garrett and James S. Liebman
What Difference Does it Make Whether Corporate Managers Have Public Responsibilities?
William H. Simon
Troubled Marriage of Retirement Security and Tax Policies
Michael J. Graetz
Voting (Insincerely) in Corporate Law
Zohar Goshen
Measuring Benchmark Damages in Antitrust Litigation
Justin McCrary and Daniel L. Rubinfeld
International Investment Law and the Extractive Industries
Ella Merrill, Jesse Coleman, Lisa E. Sachs, and Lise Johnson
*Updated as of 11/29/22.